AARP says prescription drug prices rise double the rate of inflation

03/6/2007 | MSNBC

An AARP study concludes the prices of about 200 drugs commonly used by seniors have increased at nearly twice the rate of inflation, arguing for government price regulation. Pharmaceutical Research and Manufacturers of America said the AARP report was flawed and said giving Medicare negotiating power would limit the number of drugs the agency paid for.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD